MDx-Chex® for Blood Culture Yeast (RUO), MDx-Chex® for Blood Culture GP (RUO) and MDx-Chex® for Blood Culture GN (RUO)
MDx-Chex for Blood Culture Yeast (RUO), MDx-Chex for Blood Culture GP (RUO) and MDx-Chex for Blood Culture GN (RUO) are full-process molecular quality controls designed for comprehensive molecular assay workflow validation.
Receive your quote directly from the manufacturer.
Each control contains intact, inactivated microorganisms suspended in a stabilized, blood-like matrix of red and white blood cells and blood culture media components, making them ideal for evaluating the entire molecular testing process, from extraction to detection. Supplied in single-use vials, these controls cover multiple microbial targets, pathogens and antimicrobial resistance markers, helping labs achieve reliable performance, streamlined workflows and confident results when they matter most.
For Research Use Only. Not for use in diagnostic procedures. We recommend that you verify that control target coverage is adequate for your sample-to-results system of choice.
MDx-Chex for Blood Culture Yeast (RUO)
- Full-process quality control for the validation of molecular assays that identify yeast in blood cultures
- Each kit contains 10 single-use tubes (5 Positive Control and 5 Negative Control)
- Coverage of commonly tested yeasts*
MDx-Chex for Blood Culture GP (RUO)
- Full-process quality control for the validation of molecular assays that identify Gram-positive bacteria in blood cultures
- Each kit contains 10 single-use tubes (5 Positive Control and 5 Negative Control)
- Coverage of commonly tested Gram-positive bacterial pathogens and associated antimicrobial resistance markers*
MDx-Chex for Blood Culture GN (RUO)
- Full-process quality control for the validation of molecular assays that identify Gram-negative bacteria in blood cultures
- Each kit contains 10 single-use tubes (5 Control 1 and 5 Control 2)
- Coverage of commonly tested Gram-negative bacterial pathogens and associated antimicrobial resistance markers*
*See the Instructions For Use (IFU) for full target coverage.
Brochures
MDx-Chex quality controls for sepsis testing
In this brochure, discover how you can simplify your sepsis testing quality control and reduce bench time with MDx-Chex® controls from Streck
Molecular diagnostics at a crossroads with future insights from the experts
Molecular diagnostics is reshaping how we detect and manage infectious diseases, with far-reaching implications for both patient care and translational research. In clinical settings, rapid molecular testing enables faster, more targeted treatment decisions that can significantly improve outcomes. In research laboratories, the same technologies are unlocking deeper insights into pathogen behavior, resistance mechanisms and emerging threats.
But with every advancement comes a set of challenges. Laboratories must weigh the benefits of adopting new technologies, like improved sensitivity, multiplexing and automation, against practical considerations such as validation complexity, workflow disruption and cost. The need for reliable, adaptable quality controls becomes even more critical as assays grow more sophisticated and regulatory demands increase.
In this expert roundtable—presented in partnership with Streck—leaders from the clinical and research community come together to share their experiences navigating this evolving landscape. They’ll discuss how molecular diagnostics is driving real-world impact, how their labs are adapting to new pressures, and how thoughtful implementation of innovation can yield both scientific and operational rewards.
Key learning objectives:
- How molecular diagnostics is transforming treatment strategies for serious infections
- Risks and rewards of adopting new molecular technologies
- How quality controls are adapting to support complex, multiplexed assays and evolving regulatory demands
- Practical steps laboratories are taking to improve efficiency, ensure reliability and prepare for what’s next
Whether you're optimizing workflows, evaluating new platforms or rethinking your QC approach, this session delivers expert perspectives to help you navigate the future of molecular diagnostics.
Certificate of attendance
If you attend the live forum, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand forum, you can request a certificate of attendance by emailing editor@selectscience.net.
Molecular diagnostics treat infectious disease with confidence
Find out how Streck is adapting to evolving clinical lab needs by providing quality controls for automated molecular diagnostics
Experts explore how molecular diagnostics are reshaping infectious disease testing and patient care
From sepsis to syndromic panels, this SelectScience forum discussed how molecular diagnostics is setting new standards for accuracy, efficiency, and impact
